Elanco Animal Health Incorporated (ELAN) 

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Show less

Over the last 12 months, insiders at Elanco Animal Health Incorporated have bought $2.09M and sold $0 worth of Elanco Animal Health Incorporated stock.

On average, over the past 5 years, insiders at Elanco Animal Health Incorporated have bought $2.52M and sold $3.25B worth of stock each year.

Highest buying activity among insiders over the last 12 months: Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) — $1.3M. HOOVER R DAVID (director) — $272,558. DOYLE WILLIAM F (director) — $254,700.

The last purchase of 10,000 shares for transaction amount of $102,000 was made by Kurzius Lawrence Erik (director) on 2025‑03‑11.